CHEK will be looking for FDA approval by early 2023. US Pivotal Study will take place in 2022.
Support @ 1.47 / Resistance @ 2.26 B: 1.47 - 1.60 S: 2.26 - 2.93
NASDAQ: $CHEK looks ready to Continue Its Uptrend! #Breakout
